Stock Analysis on Net

HCA Healthcare Inc. (NYSE:HCA)

This company has been moved to the archive! The financial data has not been updated since May 3, 2022.

Common Stock Valuation Ratios (Price Multiples) 

Microsoft Excel

Current Valuation Ratios

HCA Healthcare Inc., current price multiples

Microsoft Excel
HCA Healthcare Inc. Abbott Laboratories Cigna Group CVS Health Corp. Elevance Health Inc. Humana Inc. Intuitive Surgical Inc. Medtronic PLC UnitedHealth Group Inc. Health Care Equipment & Services Health Care
Selected Financial Data
Current share price (P) $216.30
No. shares of common stock outstanding 295,484,400
Growth rate (g) 686.54%
 
Earnings per share (EPS) $23.54
Next year expected EPS $185.16
Operating profit per share $38.24
Sales per share $198.83
Book value per share (BVPS) $-3.16
Valuation Ratios (Price Multiples)
Price to earnings (P/E) 9.19 35.40 16.98 9.29 16.62 13.96 102.13 31.44 24.54 25.98 23.18
Price to next year expected earnings 1.17 33.12 15.25 8.76 14.77 11.88 89.98 30.87 20.93 23.55 20.99
Price-earnings-growth (PEG) 0.01 5.15 1.49 1.52 1.33 0.80 7.57 17.15 1.42 2.52 2.22
Price to operating profit (P/OP) 5.66 31.27 10.27 5.64 13.07 8.66 103.93 22.47 16.97 19.28 19.29
Price to sales (P/S) 1.09 5.05 0.45 0.22 0.58 0.33 25.78 3.57 1.49 1.29 2.66

Based on: 10-K (reporting date: 2021-12-31).

If the company price multiple is lower then the price multiple of benchmark then company stock is relatively undervalued.
Otherwise, if the company price multiple is higher then the price multiple of benchmark then company stock is relatively overvalued.


Historical Valuation Ratios (Summary)

HCA Healthcare Inc., historical price multiples

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Price to earnings (P/E) 10.65 16.06 14.30 12.84 15.92
Price to operating profit (P/OP) 6.56 8.31 6.93 6.88 5.82
Price to sales (P/S) 1.26 1.17 0.98 1.04 0.81
Price to book value (P/BV) 105.40

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

Valuation ratio Description The company
P/E ratio The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings. HCA Healthcare Inc. P/E ratio increased from 2019 to 2020 but then decreased significantly from 2020 to 2021.
P/OP ratio Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit. HCA Healthcare Inc. P/OP ratio increased from 2019 to 2020 but then decreased significantly from 2020 to 2021.
P/S ratio An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative. HCA Healthcare Inc. P/S ratio increased from 2019 to 2020 and from 2020 to 2021.

Price to Earnings (P/E)

HCA Healthcare Inc., historical P/E calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
No. shares of common stock outstanding1 303,600,000 339,917,500 338,427,300 342,376,700 349,903,700
Selected Financial Data (US$)
Net income attributable to HCA Healthcare, Inc. (in millions) 6,956 3,754 3,505 3,787 2,216
Earnings per share (EPS)2 22.91 11.04 10.36 11.06 6.33
Share price1, 3 244.10 177.37 148.11 142.01 100.84
Valuation Ratio
P/E ratio4 10.65 16.06 14.30 12.84 15.92
Benchmarks
P/E Ratio, Competitors5
Abbott Laboratories 29.13 48.49 41.83
Cigna Group 13.43 8.71 13.26
CVS Health Corp. 17.39 12.88 14.15
Elevance Health Inc. 18.13 15.87 15.96
Humana Inc. 18.34 14.48 18.10
Intuitive Surgical Inc. 59.94 87.47 48.72
Medtronic PLC 46.56 26.30 28.78
UnitedHealth Group Inc. 26.03 20.54 20.48
P/E Ratio, Sector
Health Care Equipment & Services 25.01 21.10 21.63
P/E Ratio, Industry
Health Care 19.87 29.50 21.10

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 Data adjusted for splits and stock dividends.

2 2021 Calculation
EPS = Net income attributable to HCA Healthcare, Inc. ÷ No. shares of common stock outstanding
= 6,956,000,000 ÷ 303,600,000 = 22.91

3 Closing price as at the filing date of HCA Healthcare Inc. Annual Report.

4 2021 Calculation
P/E ratio = Share price ÷ EPS
= 244.10 ÷ 22.91 = 10.65

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/E ratio The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings. HCA Healthcare Inc. P/E ratio increased from 2019 to 2020 but then decreased significantly from 2020 to 2021.

Price to Operating Profit (P/OP)

HCA Healthcare Inc., historical P/OP calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
No. shares of common stock outstanding1 303,600,000 339,917,500 338,427,300 342,376,700 349,903,700
Selected Financial Data (US$)
Operating income (in millions) 11,298 7,255 7,236 7,070 6,065
Operating profit per share2 37.21 21.34 21.38 20.65 17.33
Share price1, 3 244.10 177.37 148.11 142.01 100.84
Valuation Ratio
P/OP ratio4 6.56 8.31 6.93 6.88 5.82
Benchmarks
P/OP Ratio, Competitors5
Abbott Laboratories 24.45 40.69 34.03
Cigna Group 9.08 9.03 8.38
CVS Health Corp. 10.43 6.65 7.83
Elevance Health Inc. 15.70 12.10 13.55
Humana Inc. 17.08 9.78 15.35
Intuitive Surgical Inc. 56.11 88.37 48.89
Medtronic PLC 37.44 26.29 21.26
UnitedHealth Group Inc. 18.77 14.12 14.40
P/OP Ratio, Sector
Health Care Equipment & Services 18.57 15.61 15.23
P/OP Ratio, Industry
Health Care 16.54 21.85 17.29

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 Data adjusted for splits and stock dividends.

2 2021 Calculation
Operating profit per share = Operating income ÷ No. shares of common stock outstanding
= 11,298,000,000 ÷ 303,600,000 = 37.21

3 Closing price as at the filing date of HCA Healthcare Inc. Annual Report.

4 2021 Calculation
P/OP ratio = Share price ÷ Operating profit per share
= 244.10 ÷ 37.21 = 6.56

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/OP ratio Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit. HCA Healthcare Inc. P/OP ratio increased from 2019 to 2020 but then decreased significantly from 2020 to 2021.

Price to Sales (P/S)

HCA Healthcare Inc., historical P/S calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
No. shares of common stock outstanding1 303,600,000 339,917,500 338,427,300 342,376,700 349,903,700
Selected Financial Data (US$)
Revenues (in millions) 58,752 51,533 51,336 46,677 43,614
Sales per share2 193.52 151.60 151.69 136.33 124.65
Share price1, 3 244.10 177.37 148.11 142.01 100.84
Valuation Ratio
P/S ratio4 1.26 1.17 0.98 1.04 0.81
Benchmarks
P/S Ratio, Competitors5
Abbott Laboratories 4.78 6.30 4.83
Cigna Group 0.42 0.46 0.44
CVS Health Corp. 0.47 0.35 0.37
Elevance Health Inc. 0.81 0.60 0.74
Humana Inc. 0.65 0.64 0.76
Intuitive Surgical Inc. 17.89 21.29 15.01
Medtronic PLC 5.57 4.36 4.36
UnitedHealth Group Inc. 1.58 1.24 1.18
P/S Ratio, Sector
Health Care Equipment & Services 1.24 1.10 1.05
P/S Ratio, Industry
Health Care 2.28 2.25 2.13

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 Data adjusted for splits and stock dividends.

2 2021 Calculation
Sales per share = Revenues ÷ No. shares of common stock outstanding
= 58,752,000,000 ÷ 303,600,000 = 193.52

3 Closing price as at the filing date of HCA Healthcare Inc. Annual Report.

4 2021 Calculation
P/S ratio = Share price ÷ Sales per share
= 244.10 ÷ 193.52 = 1.26

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/S ratio An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative. HCA Healthcare Inc. P/S ratio increased from 2019 to 2020 and from 2020 to 2021.

Price to Book Value (P/BV)

HCA Healthcare Inc., historical P/BV calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
No. shares of common stock outstanding1 303,600,000 339,917,500 338,427,300 342,376,700 349,903,700
Selected Financial Data (US$)
Stockholders’ equity (deficit) attributable to HCA Healthcare, Inc. (in millions) (933) 572 (2,808) (4,950) (6,806)
Book value per share (BVPS)2 -3.07 1.68 -8.30 -14.46 -19.45
Share price1, 3 244.10 177.37 148.11 142.01 100.84
Valuation Ratio
P/BV ratio4 105.40
Benchmarks
P/BV Ratio, Competitors5
Abbott Laboratories 5.75 6.65 4.96
Cigna Group 1.53 1.46 1.49
CVS Health Corp. 1.83 1.33 1.47
Elevance Health Inc. 3.07 2.19 2.42
Humana Inc. 3.34 3.55 4.07
Intuitive Surgical Inc. 8.59 9.53 8.13
Medtronic PLC 3.26 2.48 2.66
UnitedHealth Group Inc. 6.27 4.83 4.92
P/BV Ratio, Sector
Health Care Equipment & Services 3.77 3.20 3.08
P/BV Ratio, Industry
Health Care 4.78 4.66 4.41

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 Data adjusted for splits and stock dividends.

2 2021 Calculation
BVPS = Stockholders’ equity (deficit) attributable to HCA Healthcare, Inc. ÷ No. shares of common stock outstanding
= -933,000,000 ÷ 303,600,000 = -3.07

3 Closing price as at the filing date of HCA Healthcare Inc. Annual Report.

4 2021 Calculation
P/BV ratio = Share price ÷ BVPS
= 244.10 ÷ -3.07 =

5 Click competitor name to see calculations.